Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable – Discussion November 16, 2019 2019 | ACC | Cardiology Tags: 2019, ACC, Cardiology http://tv.clinicaltrialresults.org/file_repos/23/2451-2423.mp4 Disclosures: TBA Article Navigation Dr. Usman Baber and Dr. C. Michael Gibson Discuss: TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: The Role of the \Interventional Lipidologist\” – Sponsored by an independent educational grant from The Medicines Company”
